Main > ONCOLOGY (**) > Lymphoma>HL>Classical>R/R *** > TREAT.: > USA. M. PembrolizuMAb



USA. M. PembrolizuMAb's subsections
(*) EU Approval Date: 2017. 05.05.
(*) EU Approval Date: 2021. 03.17.>
(*) USA Approval Date: 2017. 03.14.
(*) USA Approval Date: 2020. 10.15.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 02.16.
TradeMark
TradeMark Web-Site

USA. M. PembrolizuMAb's products
This section has no products